Assistance Publique - Hôpitaux de Paris: Scleroderma, Systemic trials
The registry lists 22 Scleroderma, Systemic studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 9 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 7Phase 3 3No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study on Systemic Sclerosis and the Validation of French-language Questionnaires Assessing Disability, Quality of Life, and Disease Status.Not yet recruitingNCT07888842
- Obinutuzumab in Systemic SclerosisNot yet recruitingNCT07842523Phase 2
- Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung DiseaseNot yet recruitingNCT07827742Phase 2
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT07077304
- Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic SclerosisNot yet recruitingNCT06722105Phase 1/2
- Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell TransplantationNot yet recruitingNCT05960058
- Manufacturing of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells for Treatment of Severe Systemic SclerosisNot yet recruitingNCT05947682Not applicable
- Safety and Efficacy of Itacitinib in Adults With Systemic SclerosisRecruitingNCT04789850Phase 2
- Phenotyping of Chronic Pain in Diffused Systemic SclerodermaCompletedNCT05622578Not applicable
- Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung DiseaseCompletedNCT05533034Not applicable
- Systemic Sclerosis' Relatives ReflexCompletedNCT04917146
- Study of the Intestinal Microbiota of Patients With Systemic SclerosisStatus unknownNCT04791280
- MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic SclerosisTerminatedNCT04244916
- Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisCompletedNCT03717961Phase 3
- Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem CellsCompletedNCT02213705Phase 1/2
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
- Conception of an ICF Core Set for Systemic SclerosisCompletedNCT01848418
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- Auto-immunity and Pulmonary Arterial HypertensionCompletedNCT01208792Not applicable
- Effects of a Personalized Standardized Rehabilitation Program in Systemic SclerosisCompletedNCT00318188Not applicable